Literature DB >> 12394955

Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?

Abele Donati1, Giovanna Conti, Silvia Loggi, Cristopher Münch, Rosanna Coltrinari, Paolo Pelaia, Paolo Pietropaoli, Jean-Charles Preiser.   

Abstract

OBJECTIVE: To assess the effects of the inhibition of guanylate cyclase, an enzyme involved in sepsis-related vascular and myocardial dysfunctions, on hemodynamic variables including blood volume and pulmonary vascular permeability during septic shock.
DESIGN: Prospective, open study with repeated measurements.
SETTING: A medicosurgical intensive care unit of a university hospital. PATIENTS: Fifteen patients with septic shock associated with persisting hypotension despite conventional treatment including fluid loading, vasopressors, and inotropes.
INTERVENTIONS: A fiberoptic catheter was inserted for the determination of blood and extravascular volumes by the thermal-dye double indicator technique, using indocyanine green (COLD system). A bolus dose of methylene blue (3 mg/kg) was infused intravenously over 10 mins. COLD-derived variables were recorded before methylene blue and 20 mins, 1 hr, and 2 hrs after the end of methylene blue infusion.
MEASUREMENTS AND MAIN RESULTS: Standard hemodynamic and oxygen-derived variables; total, intrathoracic, systolic, and diastolic cardiac blood volumes; extravascular lung water; plasma osmolarity; and lactate and protein concentrations were recorded. Mean arterial and pulmonary artery pressures, systemic and pulmonary vascular resistances, and left ventricular stroke work index increased, and blood lactate transiently decreased after methylene blue (p <.05). The other variables recorded were unchanged during the 2-hr period following methylene blue infusion.
CONCLUSIONS: This study confirmed the acute vasoconstrictive and positive inotropic effects of methylene blue during septic shock. These effects were not associated with changes in blood volume, myocardial diastolic function, or pulmonary vascular permeability assessed by extravascular lung water.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394955     DOI: 10.1097/00003246-200210000-00015

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Feeling blue with metformin-associated lactic acidosis.

Authors:  Benjamin Plumb; Alex Parker; Paul Wong
Journal:  BMJ Case Rep       Date:  2013-03-01

2.  Effect of methylene blue on middle cerebral artery flow velocity in a patient with severe sepsis following clipping of a cerebral aneurysm.

Authors:  David A Zygun; Peter G Bradley; David K Menon
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.

Authors:  Takashi Sonobe; Philippe Haouzi
Journal:  Clin Toxicol (Phila)       Date:  2015-05-12       Impact factor: 4.467

4.  Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.

Authors:  John T Denny; Andrew T Burr; Fred Balzer; James T Tse; Julia E Denny; Darrick Chyu
Journal:  Exp Ther Med       Date:  2015-03-12       Impact factor: 2.447

5.  Methylene blue counteracts H2S toxicity-induced cardiac depression by restoring L-type Ca channel activity.

Authors:  Annick Judenherc-Haouzi; Xue-Qian Zhang; Takashi Sonobe; Jianliang Song; Matthew D Rannals; JuFang Wang; Nicole Tubbs; Joseph Y Cheung; Philippe Haouzi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-09       Impact factor: 3.619

Review 6.  Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.

Authors:  Anders Perner; Anthony C Gordon; Daniel De Backer; George Dimopoulos; James A Russell; Jeffrey Lipman; Jens-Ulrik Jensen; John Myburgh; Mervyn Singer; Rinaldo Bellomo; Timothy Walsh
Journal:  Intensive Care Med       Date:  2016-10-01       Impact factor: 17.440

Review 7.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

8.  High absolute bioavailability of methylene blue given as an aqueous oral formulation.

Authors:  Ingeborg Walter-Sack; Jens Rengelshausen; Heike Oberwittler; Juergen Burhenne; Olaf Mueller; Peter Meissner; Gerd Mikus
Journal:  Eur J Clin Pharmacol       Date:  2008-09-23       Impact factor: 2.953

Review 9.  Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review.

Authors:  Craig M McRobb; David W Holt
Journal:  J Extra Corpor Technol       Date:  2008-09

10.  A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.

Authors:  Rachel Erin Graham; Michaela Cartner; James Winearls
Journal:  BMJ Case Rep       Date:  2015-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.